Concepedia

Author

Vito Lampasona

Vita-Salute San Raffaele UniversityORCID

Also Known As

Alessia Mercalli, B. Keymeulen, Chandan Yaliwal, K. Fouad, K.M. Gillespie, L. A. Distiller, M Schlosser, V LAMPASONA, V Lampasona, V. Lampasona

172

Publications

9.4K

Citations

47

H-Index

98

Concepts

All Affiliations

Vita-Salute San Raffaele UniversitySan Raffaele University of RomeIstituti di Ricovero e Cura a Carattere ScientificoIstituto di Ricovero e Cura a Carattere Scientifico San RaffaeleIRCCS Ospedale San Raffaele
VL

About

Vito Lampasona is an author at Vita-Salute San Raffaele University specializing in medicine, autoimmunity, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

37

5.1K

2

Allergy

6

6

3K

3

Natural Sciences

3

3

132

4

Health Sciences

2

2

75

5

Public Health

1

1

124

Vito Lampasona

×

81

Publications

8.3K

Citations

41

H-Index

YearCitations

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang,

Science

2020

2.8K

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Tom Le Voyer,

Science Immunology

2021

600

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Stefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo,

Nature Communications

2021

373

Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies

Ezio Bonifacio, Vito Lampasona, Stefano Genovese,

The Journal of Immunology

1995

238

Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk

Peter Achenbach, Vito Lampasona, Ulrike Landherr,

Diabetologia

2009

197

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais,

Proceedings of the National Academy of Sciences

2022

180

(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial

Michele Reni, Erica Dugnani, Stefano Cereda,

Clinical Cancer Research

2015

166

Zinc Transporter 8 Antibodies Complement GAD and IA-2 Antibodies in the Identification and Characterization of Adult-Onset Autoimmune Diabetes

Vito Lampasona, Antonio Petrone, Claudio Tiberti,

Diabetes Care

2009

155

Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects

Vito Lampasona, Diego Franciotta, Roberto Furlan,

Neurology

2004

149

A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children

Markus Hippich, Lisa Holthaus, Robin Assfalg,

Med

2020

124

Page 1